Unfortunately, we don't support Internet Explorer anymore as it has been replaced by Microsoft Edge. Please try using Edge or an alternative modern browser for the best experience.
Unfortunately, we don't support Internet Explorer anymore as it has been replaced by Microsoft Edge. Please try using Edge or an alternative modern browser for the best experience.
Learn
Share
Network
Benefit
Delivering Affordable Innovation Through Global Partnerships
USAIC has created an ecosystem committed to driving a global dialogue on BioPharma & Healthcare innovation, attracting a diverse mix of senior industry professionals and catalyzing partnerships, new ideas, networks and regulatory reform. This unique platform creates mutually beneficial opportunities and relationships for the global Life Sciences & Healthcare industry.
Super Session: Honoring Dr. Stelios Papadopoulos, Chair of the Board, Exelixis with the Distinguished Service Award (5th award in 19 years).
8:15 AM – 8:45 AM
Registration and Networking
8:45 AM – 8:55 AM
Welcome address: Karun Rishi, President, USAIC
Opening comments: Dr Andrew Plump, President of Research & Development, Takeda
8:55 AM – 9:40 AM
Panel: BioPharma- Measures for Unpredictable Times
Panelists:
Christopher Viehbacher, President & CEO, Biogen
Hari Bhartia, Founder & Co-Chairman, Jubilant Bhartia Group
Sanat Chattopadhyay, President- Manufacturing, Merck & Co.
Dr. Susan Hockfield, President Emerita, Massachusetts Institute of Technology (MIT)
Moderator:
Dr. William Chin, Professor of Medicine, Emeritus, Harvard Medical School
9:40 AM – 10:25 AM
Panel: Rare & Neuro Diseases
Panelists:
Daphne Zohar, Founder & Chief Executive Officer, Seaport Therapeutics
Dr. Fiona Elwood, Vice President, Neurodegeneration DAS, J&J Innovative Medicine
Dr. Priya Singhal, Executive Vice President & Head of Development, Biogen
Dr. Nancy Andrews, Executive Vice President & CSO, Boston Children’s Hospital
Dr. Zandy Forbes, President & CEO, MeiraGTx
Moderator:
Dr. Steve Uden, Co-Founder & CEO, Rallybio
10:25 AM – 10:55 AM
Networking Break
10:55 AM – 11:40 AM
Panel: BioPharma Investment Priorities
Panelists:
Dr. Francesco De Rubertis, Co-founder & Partner, Medicxi
Dr. Kris Jenner, Co-Founder & Managing Member, Rock Springs Capital
Rajiv Kaul, Sector Portfolio Manager, Fidelity Investments
Dr. Stephen Knight, President & Senior Managing Partner, F-Prime Capital
Moderator:
Dr. Stelios Papadopoulos, Chairman of the Board, Exelixis, Inc.
11:40 AM – 12:25 PM
Panel: Clinical Trials Opportunities in India
Panelists:
Badhri Srinivasan, Executive Chairman, Unilabs
Dr. Christoph Koenen, Head of Clinical Development & Operations, Pharma R&D, Bayer
Dinkar Saran, Partner- Pharma and Life Sciences Operations, PwC
Peyton Howell, Chief Executive Officer, Parexel
Dr. Sarah Sheikh, Head of Global Development, Takeda
Moderator:
Peter Ronco, Chief Executive Officer, Emmes
12:25 PM – 1:25 PM
Lunch
1:25 PM – 2:10 PM
Panel: Oncology
Panelists:
Dr. Michael Morrissey, President & CEO, Exelixis
Dr. Paul-Peter Tak, President & CEO, Candel Therapeutics
Dr. Steve Harr, President & CEO, Sana Biotechnology
Dr. Sam Waksal, Founder, Chairman & CEO, Graviton Biosciences
Dr. Toni Choueiri, Director, Genitourinary (GU) Oncology, Dana-Farber Cancer Institute
Moderator:
Dr. Najat Khan, Chief R&D and Commercial Officer, Recursion
2:10 PM – 2:55 PM
Panel: R&D strategies in an era of unprecedented uncertainty and opportunity
Panelists:
Dr. Andrew Plump, President of Research & Development, Takeda
Dr. David Meeker, Chairman & CEO, Rhythm Pharmaceuticals
Dr. Maria Freire, Principal, The Freire Group
Dr. Mathai Mammen, Chairman & CEO, Parabilis Medicines
Moderator:
Dr. Kush Parmar, Managing Partner, 5AM Ventures
2:55 PM – 3:25 PM
Networking Break
3:25 PM – 4:10 PM
Panel: Digital & Data Science in Healthcare
Panelists:
Dr. Belen Fraile, Chief R&D Data Science Officer, Johnson & Johnson Innovative Medicine
Dr. Dina Katabi, Professor of Computer Science, Massachusetts Institute of Technology (MIT)
Dr. Nicole Glazer, Senior Vice President R&D Data, Takeda
Parag Saxena, Co-Founder & Managing Partner, Vedanta Capital
Dr. Paul Burton, Chief Medical Officer, Amgen
Moderator:
Sastry Chilukuri, Chairman & CEO, Emmes Group
4:10 PM – 4:15 PM
Closing Remarks: Dr Andrew Plump, President of Research & Development, Takeda
4:15 PM – 4:50 PM
Honouring Dr. Stelios Papadopoulos, Chairman of the Board, Exelixis, Inc. with the
Distinguished Service Award
Tributes by:
Dr. Maria Freire, Principal, The Freire Group
Dr. Francesco De Rubertis, Co-founder & Partner, Medicxi
Dr. Sam Waksal, Founder, Chairman & CEO, Graviton Biosciences
Paris Panayiotopoulos, Senior Managing Director, Blackstone Life Sciences
Christopher Viehbacher, President & CEO, Biogen
4:50 PM – 5:00 PM
BioPharma Sisterhood Group Photo
5:00 PM – 6:00 PM
Networking Reception
*Program and Speakers subject to change
Please keep your cell phone in silent mode
Click here to download a PDF of this agenda.